Clinical trials
Recruiting Phase 3 Lung Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 5 |
| 2025 | 13 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 35 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| NRG Oncology | 2 |
| Pfizer | 2 |
| Revolution Medicines, Inc. | 2 |
| Amgen | 1 |
| ArriVent BioPharma, Inc. | 1 |
| BioNTech SE | 1 |
| Eli Lilly and Company | 1 |
| Fudan University | 1 |
| George Washington University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 35 |
| Carcinoma, Non-Small-Cell Lung | 17 |
| Carcinoma | 4 |
| Neoplasms | 4 |
| Small Cell Lung Carcinoma | 3 |
| Bronchial Neoplasms | 2 |
| Colonic Neoplasms | 2 |
| Lung Diseases | 2 |
| Neoplasm Metastasis | 2 |
| Respiratory Tract Neoplasms | 2 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.